Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ERK implication in cell cycle regulation.

Jean-Claude Chambard1, Renaud Lefloch, Jacques Pouysségur

  • 1Institute of Signaling Developmental Biology and Cancer, CNRS UMR 6543, Universite de Nice-Sofia Antipolis, Centre A. Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France.

Biochimica Et Biophysica Acta
|December 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IF-CRIB: A 3D-printable device to facilitate immunofluorescence experiments and its application in screening and characterizing cells expressing a degradable form of ERK2.

Methods (San Diego, Calif.)·2025
Same author

Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis.

Current oncology (Toronto, Ont.)·2024
Same author

Revealing the Ferroptotic Phenotype of Medulloblastoma.

Journal of visualized experiments : JoVE·2024
Same author

N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2.

Nucleic acids research·2023
Same author

Editorial: Immunometabolism and therapeutic targeting of aggressive cancers.

Frontiers in oncology·2023
Same author

Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells.

Antioxidants (Basel, Switzerland)·2022

The extracellular signal-regulated kinase (ERK) pathway is crucial for cell proliferation, controlling cell cycle transitions from G1 to S and G2 to M phases. This review details ERK

Area of Science:

  • Cellular biology
  • Molecular signaling pathways
  • Cancer research

Background:

  • The Ras/Raf/MEK/ERK pathway is a central regulator of cellular responses to extracellular stimuli.
  • ERK signaling is implicated in cell proliferation, differentiation, and survival.
  • Dysregulation of ERK and PI3K pathways is common in human cancers.

Purpose of the Study:

  • To review the evidence supporting ERK's role in controlling cell proliferation.
  • To elucidate the spatio-temporal regulation of ERK signaling.
  • To examine ERK's function in cell cycle progression and its convergence with PI3K signaling.

Main Methods:

  • Literature review of studies over the last 15 years.
  • Analysis of molecular mechanisms controlling ERK activation and cell cycle events.

Related Experiment Videos

  • Examination of crosstalk between ERK, PI3K, AKT, and mTOR pathways.

    • Main Results:

    • ERK signaling is essential for controlling cell cycle progression, particularly the G1 to S and G2/M transitions.
    • Specific cellular components link extracellular signals to ERK activation and cell cycle induction.
    • ERK and AKT pathways converge to activate mTOR, highlighting a key point of synergy.
    • Constitutive activation of ERK and AKT targets is observed in numerous human cancers.

    Conclusions:

    • ERK plays a critical role in regulating cell proliferation through precise spatio-temporal control.
    • Understanding ERK pathway integration with PI3K signaling is vital for comprehending cancer development.
    • Targeted therapies focusing on ERK and AKT pathways in specific cancer patients offer therapeutic potential.